Abstract
Malignant tumors of mesenchymal tissue (sarcomas) originating from the dermis and subcutis are discussed in this chapter. In addition, some sarcomas locate in deeper soft tissue (subfascial sarcomas), and the skin may be involved secondarily by the extension of the tumor. These sarcomas are mainly diagnosed and treated by orthopedic surgeons. Sarcomas are classified according to the cell of origin. All cutaneous sarcomas of vascular, fibrous, fatty tissue, nerve sheath, and smooth muscle origin are rare. Cutaneous sarcomas with vascular differentiation are localized on relatively superficial parts of the skin and have typical clinical features, but most other sarcomas present with nonspecific nodules or poorly defined deep masses that may only be diagnosed by histopathologic examination. Cutaneous sarcomas are generally not transformed from benign skin or soft tissue tumors. While some of these cutaneous sarcomas are low grade and have a better prognosis than their counterparts in deeper tissue, many have an aggressive course with a potential for systemic metastasis. Early diagnosis is essential to decrease the morbidity and mortality of these tumors.
Keywords
- Malignant Peripheral Nerve Sheath Tumor
- Malignant Fibrous Histiocytoma
- Epithelioid Sarcoma
- Visceral Involvement
- Plexiform Neurofibroma
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSuggested Reading
Calonje JE, Brenn T, Lazar AJ, McKee PH. McKee's pathology of the skin, edn 4. China: Elsevier; 2012.
de Morais OO, de Araújo LC, Gomes CM, et al. Congenital dermatofibrosarcoma protuberans. Cutis. 2012;90:285–8.
Hendersen MT, Hollmig ST. Malignant fibrous histiocytoma: changing perceptions and management challanges. J Am Acad Dermatol. 2012;67:1335–41.
Hosseini-Moghaddam SM, Soleimanirahbar A, Mazzuli T, et al. Post renal transplantation Kaposi's sarcoma: a review of its epidemiology, pathogenesis, diagnosis, clinical aspects, and therapy. Transpl Infect Dis. 2012;14:338–45.
Johnson-Jahangir H, Ratner D. Advances in management of dermatofibrosarcoma protuberans. Dermatol Clin. 2011;29:191–200.
Régnier-Rosencher E, Guillot B, Dupin N. Treatments for classic Kaposi sarcoma: a systematic review of the literature. J Am Acad Dermatol. 2013;68:313–31.
Rigel DS, Robinson JK, Ross M, Friedman RJ, Corkerell CJ, Lim HW, Stockfleth HW, Kirkwood JM. Cancer of the skin, edn 2. China: Saunders Elsevier; 2011.
Schwartz RA. Skin cancer: recognition and management, edn 2. Singapore: Blackwell Publishing; 2008.
Sharma A, Schwartz RA. Stewart-Treves syndrome: pathogenesis and management. J Am Acad Dermatol. 2012; 67:1342–8.
Voth H, Landsberg J, Hinz T, et al. Management of dermatofibrosarcoma protuberans with fibrosarcomatous transformation: an evidence-based review of the literature. J Eur Acad Dermatol Venereol. 2011;25:1385–91.
Yaich S, Charfeddine K, Zaghdane S, et al. Sirolimus for the treatment of Kaposi sarcoma after renal transplantation: a series of 10 cases. Transplant Proc. 2012;44:2824–6.
Young RJ, Brown NJ, Reed MW, Hughes D, Woll PJ. Angiosarcoma. Lancet Oncol. 2010;11:983–91.
Ziemer M. Atypical fibroxanthoma. J Dtsch Dermatol Ges. 2012;10:537–50.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Baykal, C., Yazganoğlu, K.D. (2014). Cutaneous Sarcomas. In: Clinical Atlas of Skin Tumors. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-40938-7_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-40938-7_13
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-40937-0
Online ISBN: 978-3-642-40938-7
eBook Packages: MedicineMedicine (R0)